AdV-tk + valacyclovir
MpeTK01
Phase 1 mab completed
Quick answer
AdV-tk + valacyclovir for Malignant Pleural Effusion is a Phase 1 program (mab) at Candel Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Candel Therapeutics
- Indication
- Malignant Pleural Effusion
- Phase
- Phase 1
- Modality
- mab
- Status
- completed